These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 17478164

  • 1. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT.
    Am J Cardiol; 2007 May 01; 99(9):1312-5. PubMed ID: 17478164
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, De Felice F, Nazzaro MS, Violini R.
    Int J Cardiol; 2010 Jun 11; 141(3):304-10. PubMed ID: 19178959
    [Abstract] [Full Text] [Related]

  • 3. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 11; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 4. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 5. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):822-8. PubMed ID: 18324695
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M, Casalino L, Gnecco G, Bezante GP, Pongiglione G, Marasini M, Del Sette M, Barsotti A.
    Am Heart J; 2008 Aug 01; 156(2):356-60. PubMed ID: 18657668
    [Abstract] [Full Text] [Related]

  • 10. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C, Timmermanns I, Reissmann U, van Essen J, Schräder R.
    Catheter Cardiovasc Interv; 2008 Feb 15; 71(3):390-5. PubMed ID: 18288745
    [Abstract] [Full Text] [Related]

  • 11. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M, Bruch L, Liebner M, Schmehl I, Winkelmann A, Rux S, Sonntag S, Wulff H, Grad MO, Kleber FX.
    J Interv Cardiol; 2007 Aug 15; 20(4):275-81. PubMed ID: 17680857
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
    Alameddine F, Block PC.
    Catheter Cardiovasc Interv; 2004 Aug 15; 62(4):512-6. PubMed ID: 15274163
    [Abstract] [Full Text] [Related]

  • 13. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, Nedeltchev K, Mattle HP, Windecker S, Meier B.
    Circulation; 2012 Feb 14; 125(6):803-12. PubMed ID: 22238228
    [Abstract] [Full Text] [Related]

  • 14. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
    Jesurum JT, Fuller CJ, Renz J, Krabill KA, Spencer MP, Reisman M.
    JACC Cardiovasc Interv; 2009 Jun 14; 2(6):561-7. PubMed ID: 19539262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.
    Catheter Cardiovasc Interv; 2007 Sep 14; 70(3):429-33. PubMed ID: 17722021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM, Sommer RJ, Levchuck SG.
    Catheter Cardiovasc Interv; 2006 Jul 14; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.